Skip to main content

FSCDR 2025 Annual Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Livestream

On Demand

Meal

Ticketed Event

Eric Wu, PhD

Associate Director, biostatistics
Novo Nordisk Inc
Lexington, Kentucky, United States

Presentation(s):

Etavopivat Reduces Incidence of Vaso-Occlusive Crises in Patients with Sickle Cell Disease: HIBISCUS Trial Phase 2 Results through 52 Weeks

Saturday, June 7, 2025
9:00 AM - 9:20 AM ET